WPRIM Management System> DCMS> Journal of Gynecologic Oncology> 2019> 30> 4

Volume: 30 Issue: 4

1. Adjuvant chemotherapy in locally advanced cervical cancer: the ceiling remains unbroken Page:e97—
2. The 34th Annual Meeting of the Korean Society of Gynecologic Oncology 2019: meeting report Page:e91—
3. Actinomycin D shortage in the Brazilian market: new challenges for successful treatment of gestational trophoblastic neoplasia Page:e87—
4. A randomized controlled trial comparing concurrent chemoradiation versus concurrent chemoradiation followed by adjuvant chemotherapy in locally advanced cervical cancer patients: ACTLACC trial Page:e82—
5. Clinical significance of variants of unknown significances in BRCA genes Page:e80—
6. The current situation of the levonorgestrel intrauterine system (LNG-IUS) in conservative treatment for patients with early-stage endometrial cancer and atypical hyperplasia Page:e79—
7. Prediction of survival outcomes in patients with epithelial ovarian cancer using machine learning methods Page:e65—
8. Prognostic importance of atypical endometriosis with architectural hyperplasia versus cytologic atypia in endometriosis-associated ovarian cancer Page:e63—
9. Conservative hysteroscopic treatment of stage I well differentiated endometrial cancer in patients with high surgical risk: a pilot study Page:e62—
10. A pilot study of gonadotropin-releasing hormone agonist combined with aromatase inhibitor as fertility-sparing treatment in obese patients with endometrial cancer Page:e61—
11. The influence of BRCA variants of unknown significance on cancer risk management decision-making Page:e60—
12. Pharmacokinetics of cisplatin during open and minimally-invasive secondary cytoreductive surgery plus HIPEC in women with platinum-sensitive recurrent ovarian cancer: a prospective study Page:e59—
13. Clinical comparison between neuroendocrine and endometrioid type carcinoma of the uterine corpus Page:e58—
14. Efficacy and fertility outcomes of levonorgestrel-releasing intra-uterine system treatment for patients with atypical complex hyperplasia or endometrial cancer: a retrospective study Page:e57—
15. Early experiences with PD-1 inhibitor treatment of platinum resistant epithelial ovarian cancer Page:e56—
16. Stage and histology of cervical cancer in women under 25 years old Page:e55—
17. Uterine smooth muscle tumor of uncertain malignant potential: fertility and clinical outcomes Page:e54—
18. Impact of vaginal brachytherapy in intermediate and high-intermediate risk endometrial cancer: a multicenter study from the FRANCOGYN group Page:e53—
19. Human papillomavirus genotype-specific risk in cervical carcinogenesis Page:e52—
20. Effects of hormone therapy on recurrence in endometrial cancer survivors: a nationwide study using the Korean Health Insurance Review and Assessment Service database Page:e51—

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.